Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A leukemia and drug technology, applied in drug combinations, antineoplastic drugs, pharmaceutical formulations, etc., can solve problems such as damage to the gastrointestinal mucosa, decreased immunity, and many side effects
Inactive Publication Date: 2008-04-30
时竹明
View PDF0 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, Western medicine chemotherapy drugs have too many side effects, such as killing and inhibiting normal hematopoietic cells, leading to anemia and bleeding; inhibiting normal immune function, reducing the body's immunity, and easily merging with various infections; damaging the gastrointestinal mucosa, leading to anorexia, nausea, and vomiting ; Affect the function of heart, liver and kidney. No matter how high the dose is, it is impossible to completely kill leukemia cells in the body. Residual leukemia cells are always the root of disease recurrence
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0009] The composition is: V A 10 mg, V E 100mg, V D3 0.5mg, V B1 60mg, V B2 30mg, V B6 60mg, Niacin 50mg, V C 300mg, biotin 0.9mg, pantothenic acid 60mg, folic acid 15mg, V B12 0.5mg, zinc 15mg, iron 2mg, troxerutin 120mg, rutin 10mg, aspirin 0mg.
[0010] How to take it: Take it three times a day.
Embodiment 2
[0012] The composition is: V A 0.9 mg, V E 200mg, V D3 0.75mg, V B1 45 mg, V B2 20mg, V B6 45mg, Niacin 150mg, V C 200mg, biotin 0.6mg, pantothenic acid 40mg, folic acid 0.7mg, V B12 0.3mg, zinc 12mg, iron 3mg, troxerutin 240mg, rutin 25mg, aspirin 300mg.
[0013] How to take it: Take it three times a day.
Embodiment 3
[0015] The composition is: V A 0.7 mg, V E 300mg, V D3 1 mg, V B1 30mg, V B2 10 mg, V B6 30mg, Niacin 300mg, V C 100mg, biotin 0.3mg, pantothenic acid 25mg, folic acid 5mg, V B12 0.125mg, zinc 10mg, iron 4mg, troxerudin 360mg, rutin 40mg, aspirin 600mg.
[0016] How to take it: Take it three times a day.
[0017] Explanation: The prescriptions of the above three examples belong to the three treatment stages of moderate and severe patients. Example 1 is suitable for the first stage for about 5-7 days, Example 2 belongs to the second stage, and Example 3 belongs to the third stage . The prescription of the whole course of treatment should be relatively dynamic and change with the recovery of hematopoietic function, mainly due to the body’s response to V E The adaptability of , troxalutin, and aspirin is generally increased, and the dosage of niacin is also increased with the improvement of the disease, and the others are reduced with the improvement of the body and...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a medicament for treating leukemia comprising components as follows, whose weight unit is mg, VA 5-10mg, VE 100-300mg, VD3 0.5-1mg, VB1 30-60mg, VB2 10-30mg, VB6 30-60mg , nicotinic acid 50-300mg, VC 100-300mg, biotin 0.3-0.9mg, pantothenic acid 25-60mg, folic acid 5-15mg, VB12 0.125-0.5mg, zinc 10-15mg, ferrum 2-4mg, troxerutin 120-360mg, birutan 10-40mg and aspirin 0-600mg. The invention receives the theory of the traditional Chinese and western medicine, which is made from seventeen medicaments selected carefully and composed scientifically. The invention indicates a radical approach for treating cancer completely and provides the medicament with a high healing and small side effects in which treatment of cancer and alimentology are associated perfectly.
Description
technical field [0001] The invention relates to a medicine for treating leukemia. Background technique [0002] Leukemia is a malignant disease of the hematopoietic system, commonly known as "blood cancer", and is one of the top ten high-incidence malignant tumors in China. Cells) progressive and uncontrolled abnormal proliferation in bone marrow or other hematopoietic tissues, infiltrate and damage various tissues, and produce different symptoms. Clinical manifestations are characterized by fever, hemorrhage, anemia, enlargement of liver, spleen, and lymph nodes. Leukemia is generally divided into acute and chronic according to the natural course of the disease and the degree of immaturity of the cells. According to the cell type, it is divided into granulocytes, lymphocytes, monocytes and other types. The clinical manifestations are different. In recent years, with the development of medical technology, methods such as chemotherapy and radiotherapy can be used to curb di...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more